vosaroxin
Showing 1 - 8 of 8
MDS Trial in Saint Louis (vosaroxin, Azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes
- vosaroxin
- Azacitidine
-
Saint Louis, MissouriWashington University School of Medicine
Mar 23, 2022
Leukemia Trial in Houston (Vosaroxin, Decitabine)
Completed
- Leukemia
- Vosaroxin
- Decitabine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 13, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Cytarabine
- Vosaroxin
-
New Haven, Connecticut
- +2 more
Sep 8, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2) Trial in Essen, Oldenburg, Ulm (Vosaroxin,
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
- Vosaroxin
- Azacitidine
-
Essen, Germany
- +2 more
Oct 27, 2020
Myelodysplastic Syndrome Trial in New York (Vosaroxin)
Completed
- Myelodysplastic Syndrome
- Vosaroxin
-
New York, New YorkWeill Cornell Medical College
Jan 24, 2019
Leukemia, Lymphocytic, Acute, Leukemia, Nonlymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in United States (Vosaroxin)
Completed
- Leukemia, Lymphocytic, Acute
- +3 more
- Vosaroxin
-
Tampa, Florida
- +4 more
Mar 28, 2017